Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor subtype 2C (5-HT2C) is a G protein-coupled receptor (GPCR) that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5-HT). It plays a critical role in modulating various central nervous system functions, including appetite, anxiety, and mood. Dysregulation is implicated in psychiatric disorders and metabolic conditions, making it a therapeutic target.
Agonist or antagonist binding modulates downstream signaling pathways, including Gq/11-PLCβ-IP3/DAG and other pathways (e.g., ERK, nitric oxide).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor Subtype 2C (5-HT2C).